TY - JOUR
T1 - A multi-centre case series of patients with coexistent intracranial hypertension and malignant arterial hypertension
AU - Sattarova, Victoria
AU - Flowers, Alexis
AU - Gospe, Sidney M.
AU - Chen, John J.
AU - Stunkel, Leanne
AU - Bhatti, M. Tariq
AU - Dattilo, Michael
AU - Kedar, Sachin
AU - Biousse, Valerie
AU - McClelland, Collin M.
AU - Lee, Michael S.
N1 - Funding Information:
None of the authors have any disclosures relevant to this submission. Michael S Lee, MD receives royalties from Uptodate and Springer, receives research support from Invex, owns stock in Horizon, and serves as a consultant for Panbela. John Chen, MD, PhD serves as a consultant to Roche, UCB, and Horizon. Sidney Gospe MD has received support from the NIH. M. Tariq Bhatti, MD has served as a consultant for Bristol Meyers Squbb and Sanofi Genzyme. Valerie Biousse has served as a consultant for Gensight and Neurophoenix. Leanne Stunkel MD has no disclosures. Michael Dattilo, MD, PhD has no disclosures. Alexis Flowers, MD has no disclosures. Collin McClelland, MD has no disclosures. Victoria Sattarova, MD has no disclosures. Sachin Kedar, MD has not disclosures.
Publisher Copyright:
© 2023, The Author(s), under exclusive licence to The Royal College of Ophthalmologists.
PY - 2023
Y1 - 2023
N2 - Objective: To describe the clinical characteristics, outcomes, and management of a large cohort of patients with concomitant malignant arterial hypertension and intracranial hypertension. Methods: Design: Retrospective case series. Subjects: Patients aged ≥ 18 years with bilateral optic disc oedema (ODE), malignant arterial hypertension and intracranial hypertension at five academic institutions. Patient demographics, clinical characteristics, diagnostic studies, and management were collected. Results: Nineteen patients (58% female, 63% Black) were included. Median age was 35 years; body mass index (BMI) was 30 kg/m2. Fourteen (74%) patients had pre-existing hypertension. The most common presenting symptom was blurred vision (89%). Median blood pressure (BP) was 220 mmHg systolic (IQR 199–231.5 mmHg) and 130 mmHg diastolic (IQR 116–136 mmHg) mmHg), and median lumbar puncture opening pressure was 36.5 cmH2O. All patients received treatment for arterial hypertension. Seventeen (89%) patients received medical treatment for raised intracranial pressure, while six (30%) patients underwent a surgical intervention. There was significant improvement in ODE, peripapillary retinal nerve fibre layer thickness, and visual field in the worst eye (p < 0.05). Considering the worst eye, 9 (47%) presented with acuity ≥ 20/25, while 5 (26%) presented with ≤ 20/200. Overall, 7 patients maintained ≥ 20/25 acuity or better, 6 demonstrated improvement, and 5 demonstrated worsening. Conclusions: Papilloedema and malignant arterial hypertension can occur simultaneously with potentially greater risk for severe visual loss. Clinicians should consider a workup for papilloedema among patients with significantly elevated blood pressure and bilateral optic disc oedema.
AB - Objective: To describe the clinical characteristics, outcomes, and management of a large cohort of patients with concomitant malignant arterial hypertension and intracranial hypertension. Methods: Design: Retrospective case series. Subjects: Patients aged ≥ 18 years with bilateral optic disc oedema (ODE), malignant arterial hypertension and intracranial hypertension at five academic institutions. Patient demographics, clinical characteristics, diagnostic studies, and management were collected. Results: Nineteen patients (58% female, 63% Black) were included. Median age was 35 years; body mass index (BMI) was 30 kg/m2. Fourteen (74%) patients had pre-existing hypertension. The most common presenting symptom was blurred vision (89%). Median blood pressure (BP) was 220 mmHg systolic (IQR 199–231.5 mmHg) and 130 mmHg diastolic (IQR 116–136 mmHg) mmHg), and median lumbar puncture opening pressure was 36.5 cmH2O. All patients received treatment for arterial hypertension. Seventeen (89%) patients received medical treatment for raised intracranial pressure, while six (30%) patients underwent a surgical intervention. There was significant improvement in ODE, peripapillary retinal nerve fibre layer thickness, and visual field in the worst eye (p < 0.05). Considering the worst eye, 9 (47%) presented with acuity ≥ 20/25, while 5 (26%) presented with ≤ 20/200. Overall, 7 patients maintained ≥ 20/25 acuity or better, 6 demonstrated improvement, and 5 demonstrated worsening. Conclusions: Papilloedema and malignant arterial hypertension can occur simultaneously with potentially greater risk for severe visual loss. Clinicians should consider a workup for papilloedema among patients with significantly elevated blood pressure and bilateral optic disc oedema.
UR - http://www.scopus.com/inward/record.url?scp=85165572521&partnerID=8YFLogxK
U2 - 10.1038/s41433-023-02672-z
DO - 10.1038/s41433-023-02672-z
M3 - Article
C2 - 37491440
AN - SCOPUS:85165572521
SN - 0950-222X
JO - Eye (Basingstoke)
JF - Eye (Basingstoke)
ER -